Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Bharat Immunologicals Biologicals Corp Ltd is 'Strong Sell'. Macroaxis provides Bharat Immunologicals buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BIBCL positions. The advice algorithm takes into account all of Bharat Immunologicals available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BIBCL buy-and-hold prospective. Check also Bharat Immunologicals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.
For the selected time horizon Bharat Immunologicals Biologicals Corp Ltd has a mean deviation of 2.1, semi deviation of 0.0, standard deviation of 3.05, variance of 9.31, downside variance of 0.0 and semi variance of 0.0We provide buy or sell advice to complement the prevailing expert consensus on Bharat Immunologicals. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Bharat Immunologicals is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Operating Margin, Revenue, Debt to Equity, as well as the relationship between Price to Earning and Net Income .
Odds of Distress
Bharat Immunologicals Returns Distribution Density
|Mean Return||0.65||Value At Risk||6.42|
|Potential Upside||4.57||Standard Deviation||3.05|
Bharat Immunologicals Greeks
|Alpha over DOW||=||0.43|
|Beta against DOW||=||1.48|
Bharat Immunologicals Volatility Alert
Bharat Immunologicals Biologicals Corp Ltd exhibits very low volatility with skewness of 0.15 and kurtosis of 2.08. However, we advise investors to further study Bharat Immunologicals Biologicals Corp Ltd technical indicators to make sure all market info is available and is reliable.
|Better Than Average||Worse Than Average||Compare Bharat Immunologicals to competition|
Bharat Immunologicals Fundamental Vs Peers
|Fundamentals||Bharat Immunologicals||Peer Average|
|Return On Equity||(10.18)%||(15.17)%|
|Return On Asset||(9.86)%||(15.64)%|
|Price to Earning||262.88X||40.69X|
|Price to Book||1.12X||14.44X|
|Price to Sales||1.10X||17.81X|
|Cash and Equivalents||182.85M||3.89B|
|Cash per Share||4.25X||5.17X|
|Debt to Equity||3.80%||0.72%|
|Book Value Per Share||7.91X||13.64X|
|Earnings Per Share||(0.99)X||2.30X|
|Number of Employees||5||10.67K|
|Bharat Immunologicals generates negative expected return over the last 30 days|
|Bharat Immunologicals has high historical volatility and very poor performance|
|Bharat Immunologicals has high likelihood to experience some financial distress in the next 2 years|
|The company reported revenue of 347.2M. Net Loss for the year was (42.69M) with profit before overhead, payroll, taxes, and interest of 75.53M.|
Check also Bharat Immunologicals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.